Evidence map›Paper›PMID 14506021›Full record

ArticleAntimicrobial agents and chemotherapy2003

Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.

L M Best, D J M Haldane, M Keelan, D E Taylor, A B R Thomson, V Loo, C A Fallone, P Lyn, F M Smaill, R Hunt and 5 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Antibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. [Comparison of Epsilometer test and agar dilution method in detecting the sensitivity ofBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2023
    Article
  6. Article
  7. Efficacy of Disc Diffusion and Agar Dilution Methods in EvaluatingMiddle East journal of digestive diseases · 2022
    Article
  8. Increased Antibiotic Resistance in Children withPathogens (Basel, Switzerland) · 2022
    Article
  9. Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2020
    Article
  10. Article
  11. Daphnetin: A Novel Anti-International journal of molecular sciences · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2010
    Article
  17. Pyrosequencing assay to rapidly detect clarithromycin resistance mutations in Canadian Helicobacter pylori isolates.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2009
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

L M BestQueen Elizabeth II Center for Clinical Research, Halifax, Canada. lbest@ns.sympatico.ca
D J M Haldane
M Keelan
D E Taylor
A B R Thomson
V Loo
C A Fallone
P Lyn
F M Smaill
R Hunt
C Gaudreau
J Kennedy
M Alfa
R Pelletier
S J O Veldhuyzen Van Zanten
McMaster University · CAUniversity of Alberta · CACenter for Clinical Research (United States) · USMcGill University Health Centre · CASt. Boniface Hospital · CACentre hospitalier universitaire de Québec · CADalhousie University · CAHôpital Saint-Luc · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Susceptibility testing was performed at seven Canadian microbiology laboratories and the Helicobacter Reference Laboratory, Halifax, Nova Scotia, Canada, to assess susceptibility testing proficiency and the reproducibility of the results for clarithromycin and metronidazole and to compare the Epsilometer test (E test) method to the agar dilution reference method. Control strain Helicobacter pylori ATCC 43504 (American Type Culture Collection) and 13 clinical isolates (plus duplicates of four of these strains including ATCC 43504) were tested blindly. The National Committee for Clinical Laboratory Standards (NCCLS) guidelines for agar dilution testing were followed, and the same suspension of organisms was used for agar dilution and E test. Antimicrobials and E test strips were provided to the investigators. Methods were provided on a website (www.Helicobactercanada.org). Each center reported MICs within the stated range for strain ATCC 43504. Compared to the average MICs, interlaboratory agreements within 2 log(2) dilutions were 90% (range, 69 to 100%) for clarithromycin by agar dilution, with seven very major errors [VMEs], and 85% (range, 65 to 100%) by E test, with three VMEs. Interlaboratory agreements within 2 log(2) dilutions were 83% (range, 50 to 100%) for metronidazole by agar dilution, with six VMEs and eight major errors (MEs), and 75% (range, 50 to 94%) by E test, with four VMEs and four MEs. At lower and higher concentrations of antibiotic, E test MICs were slightly different from agar dilution MICs, but these differences did not result in errors. When a standardized protocol based on NCCLS guidelines was used, most participants in this study correctly identified clarithromycin- and metronidazole-susceptible and -resistant strains of H. pylori 93% of the time by either the agar dilution or E test method, and the numbers of errors were relatively equivalent by both methods.

Indexed as

ClarithromycinColony Count, MicrobialCulture MediaDrug Resistance, BacterialHelicobacter pyloriLaboratoriesMetronidazoleMicrobial Sensitivity TestsReference StandardsReproducibility of ResultsStatistics as TopicClarithromycinCulture MediaMetronidazole

Identifiers

PMID14506021
PMCPMC201128
OpenAlexW2114582107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.